Table 4. Rate of stent thrombosis according to ARC classification during 5 years of follow-up.
Classification | BMS | DES |
P value (three-way BMS/PES/DES) | |
---|---|---|---|---|
PES | SES | |||
Definite | 0.5 | |||
0-30 days | 0 | 0 | 0 | |
30 days -1 year | 0 | 1.9 | 0.9 | |
1-2 years | 0 | 0 | 0.9 | |
2-3 years | 0 | 0 | 0 | |
3-4 years | 0 | 0 | 0 | |
4-5 years | 0 | 1 | 0 | |
All (5-year cumulative) | 0 | 2.9 | 1.8 | |
Definite or probable | 0.4 | |||
0-30 days | 0 | 0 | 0.9 | |
30 days -1 year | 0 | 1.9 | 0.9 | |
1-2 years | 0 | 0 | 0.9 | |
2-3 years | 0 | 0 | 0 | |
3-4 years | 0 | 0 | 0 | |
4-5 years | 0 | 1 | 0 | |
All (5-year cumulative) | 0 | 2.9 | 2.9 | |
Definite, probable or possible | 0.2 | |||
0-30 days | 0 | 0 | 0.9 | |
30 days -1 year | 0 | 2.8 | 0.9 | |
1-2 years | 0 | 0 | 0.9 | |
2-3 years | 0 | 0 | 1 | |
3-4 years | 0 | 1 | 0 | |
4-5 years | 0 | 2.1 | 0 | |
All (5-year cumulative) | 0 | 5.9 | 4.7 |
Numbers are proportions. BMS, bare metal stent; PES, paclitaxel-eluting stet; SES, sirolimus-eluting stent; DES, drug eluting stents.